Drug Shortage Report for NORMOSOL-R
Report ID | 114801 |
Drug Identification Number | 00039500 |
Brand name | NORMOSOL-R |
Common or Proper name | Multiple Electrolytes Injection Type 1 USP |
Company Name | ICU MEDICAL CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | POTASSIUM CHLORIDE MAGNESIUM CHLORIDE SODIUM CHLORIDE SODIUM ACETATE SODIUM GLUCONATE |
Strength(s) | 0.037G 0.014G 0.526G 0.222G 0.502G |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1000 mL |
ATC code | B05BB |
ATC description | I.V. SOLUTIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-04-20 |
Actual start date | |
Estimated end date | |
Actual end date | 2020-05-13 |
Shortage status | Resolved |
Updated date | 2020-05-14 |
Company comments | This issue has been resolved. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2600 BOUL ALFRED-NOBEL, SUITE 100 SAINT LAURENT, QUEBEC CANADA H4S 0A9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2020-05-14 | English | Compare |
v4 | 2020-05-13 | French | Compare |
v3 | 2020-05-13 | English | Compare |
v2 | 2020-05-11 | French | Compare |
v1 | 2020-05-11 | English | Compare |
Showing 1 to 5 of 5